Global Pulmonary Drug Delivery Systems Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Page: 119

Published Date: 18 Mar 2023

Category: Medical Devices & Consumables

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Related Reports
Product Tags

Description

Pulmonary drug delivery systems are used to the treatment of various respiratory diseases like asthma and chronic obstructive pulmonary disease (COPD), delivering locally acting drugs directly to their site of action. Advantages of pulmonary drug delivery systems over oral drugs is the excellent capability of absorbing pharmaceuticals, due to the large absorptive surface area of lungs (approximately 70-140 m2 in adult humans having extremely thin absorptive mucosal membrane) and good blood supply.

According to our (Global Info Research) latest study, the global Pulmonary Drug Delivery Systems market size was valued at USD 3134.3 million in 2022 and is forecast to a readjusted size of USD 4129.9 million by 2029 with a CAGR of 4.0% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

The major players in global Pulmonary Drug Delivery Systems market include 3M, GSK, AstraZeneca, etc. The top 3 players occupy about 60% shares of the global market. Europe and North America are main markets, they occupy over 75% of the global market. Metered Dose Inhaler (MDI) is the main type, with a share over 60%. COPD is the main application, which holds a share over 50%.

This report is a detailed and comprehensive analysis for global Pulmonary Drug Delivery Systems market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:
Global Pulmonary Drug Delivery Systems market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Pulmonary Drug Delivery Systems market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Pulmonary Drug Delivery Systems market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Pulmonary Drug Delivery Systems market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (USD/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Pulmonary Drug Delivery Systems
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Pulmonary Drug Delivery Systems market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include 3M, GSK, AstraZeneca, Cipla and Chiesi, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market Segmentation
Pulmonary Drug Delivery Systems market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
    Nebulizers
    Dry Powder Inhaler (DPI)
    Metered Dose Inhaler (MDI)

Market segment by Application
    COPD
    Asthma
    Others

Major players covered
    3M
    GSK
    AstraZeneca
    Cipla
    Chiesi
    Boehringer Ingelheim
    Aptar
    Novartis
    Philips Respironics
    Omron Healthcare
    PARI
    Skyepharma
    CareFusion
    Shanghai Huarui
    Taian Character
    Chia Tai Tianqing

Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Pulmonary Drug Delivery Systems product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Pulmonary Drug Delivery Systems, with price, sales, revenue and global market share of Pulmonary Drug Delivery Systems from 2018 to 2023.
Chapter 3, the Pulmonary Drug Delivery Systems competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Pulmonary Drug Delivery Systems breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Pulmonary Drug Delivery Systems market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Pulmonary Drug Delivery Systems.
Chapter 14 and 15, to describe Pulmonary Drug Delivery Systems sales channel, distributors, customers, research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Pulmonary Drug Delivery Systems
    1.2 Market Estimation Caveats and Base Year
    1.3 Market Analysis by Type
        1.3.1 Overview: Global Pulmonary Drug Delivery Systems Consumption Value by Type: 2018 Versus 2022 Versus 2029
        1.3.2 Nebulizers
        1.3.3 Dry Powder Inhaler (DPI)
        1.3.4 Metered Dose Inhaler (MDI)
    1.4 Market Analysis by Application
        1.4.1 Overview: Global Pulmonary Drug Delivery Systems Consumption Value by Application: 2018 Versus 2022 Versus 2029
        1.4.2 COPD
        1.4.3 Asthma
        1.4.4 Others
    1.5 Global Pulmonary Drug Delivery Systems Market Size & Forecast
        1.5.1 Global Pulmonary Drug Delivery Systems Consumption Value (2018 & 2022 & 2029)
        1.5.2 Global Pulmonary Drug Delivery Systems Sales Quantity (2018-2029)
        1.5.3 Global Pulmonary Drug Delivery Systems Average Price (2018-2029)

2 Manufacturers Profiles
    2.1 3M
        2.1.1 3M Details
        2.1.2 3M Major Business
        2.1.3 3M Pulmonary Drug Delivery Systems Product and Services
        2.1.4 3M Pulmonary Drug Delivery Systems Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.1.5 3M Recent Developments/Updates
    2.2 GSK
        2.2.1 GSK Details
        2.2.2 GSK Major Business
        2.2.3 GSK Pulmonary Drug Delivery Systems Product and Services
        2.2.4 GSK Pulmonary Drug Delivery Systems Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.2.5 GSK Recent Developments/Updates
    2.3 AstraZeneca
        2.3.1 AstraZeneca Details
        2.3.2 AstraZeneca Major Business
        2.3.3 AstraZeneca Pulmonary Drug Delivery Systems Product and Services
        2.3.4 AstraZeneca Pulmonary Drug Delivery Systems Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.3.5 AstraZeneca Recent Developments/Updates
    2.4 Cipla
        2.4.1 Cipla Details
        2.4.2 Cipla Major Business
        2.4.3 Cipla Pulmonary Drug Delivery Systems Product and Services
        2.4.4 Cipla Pulmonary Drug Delivery Systems Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.4.5 Cipla Recent Developments/Updates
    2.5 Chiesi
        2.5.1 Chiesi Details
        2.5.2 Chiesi Major Business
        2.5.3 Chiesi Pulmonary Drug Delivery Systems Product and Services
        2.5.4 Chiesi Pulmonary Drug Delivery Systems Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.5.5 Chiesi Recent Developments/Updates
    2.6 Boehringer Ingelheim
        2.6.1 Boehringer Ingelheim Details
        2.6.2 Boehringer Ingelheim Major Business
        2.6.3 Boehringer Ingelheim Pulmonary Drug Delivery Systems Product and Services
        2.6.4 Boehringer Ingelheim Pulmonary Drug Delivery Systems Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.6.5 Boehringer Ingelheim Recent Developments/Updates
    2.7 Aptar
        2.7.1 Aptar Details
        2.7.2 Aptar Major Business
        2.7.3 Aptar Pulmonary Drug Delivery Systems Product and Services
        2.7.4 Aptar Pulmonary Drug Delivery Systems Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.7.5 Aptar Recent Developments/Updates
    2.8 Novartis
        2.8.1 Novartis Details
        2.8.2 Novartis Major Business
        2.8.3 Novartis Pulmonary Drug Delivery Systems Product and Services
        2.8.4 Novartis Pulmonary Drug Delivery Systems Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.8.5 Novartis Recent Developments/Updates
    2.9 Philips Respironics
        2.9.1 Philips Respironics Details
        2.9.2 Philips Respironics Major Business
        2.9.3 Philips Respironics Pulmonary Drug Delivery Systems Product and Services
        2.9.4 Philips Respironics Pulmonary Drug Delivery Systems Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.9.5 Philips Respironics Recent Developments/Updates
    2.10 Omron Healthcare
        2.10.1 Omron Healthcare Details
        2.10.2 Omron Healthcare Major Business
        2.10.3 Omron Healthcare Pulmonary Drug Delivery Systems Product and Services
        2.10.4 Omron Healthcare Pulmonary Drug Delivery Systems Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.10.5 Omron Healthcare Recent Developments/Updates
    2.11 PARI
        2.11.1 PARI Details
        2.11.2 PARI Major Business
        2.11.3 PARI Pulmonary Drug Delivery Systems Product and Services
        2.11.4 PARI Pulmonary Drug Delivery Systems Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.11.5 PARI Recent Developments/Updates
    2.12 Skyepharma
        2.12.1 Skyepharma Details
        2.12.2 Skyepharma Major Business
        2.12.3 Skyepharma Pulmonary Drug Delivery Systems Product and Services
        2.12.4 Skyepharma Pulmonary Drug Delivery Systems Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.12.5 Skyepharma Recent Developments/Updates
    2.13 CareFusion
        2.13.1 CareFusion Details
        2.13.2 CareFusion Major Business
        2.13.3 CareFusion Pulmonary Drug Delivery Systems Product and Services
        2.13.4 CareFusion Pulmonary Drug Delivery Systems Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.13.5 CareFusion Recent Developments/Updates
    2.14 Shanghai Huarui
        2.14.1 Shanghai Huarui Details
        2.14.2 Shanghai Huarui Major Business
        2.14.3 Shanghai Huarui Pulmonary Drug Delivery Systems Product and Services
        2.14.4 Shanghai Huarui Pulmonary Drug Delivery Systems Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.14.5 Shanghai Huarui Recent Developments/Updates
    2.15 Taian Character
        2.15.1 Taian Character Details
        2.15.2 Taian Character Major Business
        2.15.3 Taian Character Pulmonary Drug Delivery Systems Product and Services
        2.15.4 Taian Character Pulmonary Drug Delivery Systems Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.15.5 Taian Character Recent Developments/Updates
    2.16 Chia Tai Tianqing
        2.16.1 Chia Tai Tianqing Details
        2.16.2 Chia Tai Tianqing Major Business
        2.16.3 Chia Tai Tianqing Pulmonary Drug Delivery Systems Product and Services
        2.16.4 Chia Tai Tianqing Pulmonary Drug Delivery Systems Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.16.5 Chia Tai Tianqing Recent Developments/Updates

3 Competitive Environment: Pulmonary Drug Delivery Systems by Manufacturer
    3.1 Global Pulmonary Drug Delivery Systems Sales Quantity by Manufacturer (2018-2023)
    3.2 Global Pulmonary Drug Delivery Systems Revenue by Manufacturer (2018-2023)
    3.3 Global Pulmonary Drug Delivery Systems Average Price by Manufacturer (2018-2023)
    3.4 Market Share Analysis (2022)
        3.4.1 Producer Shipments of Pulmonary Drug Delivery Systems by Manufacturer Revenue ($MM) and Market Share (%): 2022
        3.4.2 Top 3 Pulmonary Drug Delivery Systems Manufacturer Market Share in 2022
        3.4.2 Top 6 Pulmonary Drug Delivery Systems Manufacturer Market Share in 2022
    3.5 Pulmonary Drug Delivery Systems Market: Overall Company Footprint Analysis
        3.5.1 Pulmonary Drug Delivery Systems Market: Region Footprint
        3.5.2 Pulmonary Drug Delivery Systems Market: Company Product Type Footprint
        3.5.3 Pulmonary Drug Delivery Systems Market: Company Product Application Footprint
    3.6 New Market Entrants and Barriers to Market Entry
    3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region
    4.1 Global Pulmonary Drug Delivery Systems Market Size by Region
        4.1.1 Global Pulmonary Drug Delivery Systems Sales Quantity by Region (2018-2029)
        4.1.2 Global Pulmonary Drug Delivery Systems Consumption Value by Region (2018-2029)
        4.1.3 Global Pulmonary Drug Delivery Systems Average Price by Region (2018-2029)
    4.2 North America Pulmonary Drug Delivery Systems Consumption Value (2018-2029)
    4.3 Europe Pulmonary Drug Delivery Systems Consumption Value (2018-2029)
    4.4 Asia-Pacific Pulmonary Drug Delivery Systems Consumption Value (2018-2029)
    4.5 South America Pulmonary Drug Delivery Systems Consumption Value (2018-2029)
    4.6 Middle East and Africa Pulmonary Drug Delivery Systems Consumption Value (2018-2029)

5 Market Segment by Type
    5.1 Global Pulmonary Drug Delivery Systems Sales Quantity by Type (2018-2029)
    5.2 Global Pulmonary Drug Delivery Systems Consumption Value by Type (2018-2029)
    5.3 Global Pulmonary Drug Delivery Systems Average Price by Type (2018-2029)

6 Market Segment by Application
    6.1 Global Pulmonary Drug Delivery Systems Sales Quantity by Application (2018-2029)
    6.2 Global Pulmonary Drug Delivery Systems Consumption Value by Application (2018-2029)
    6.3 Global Pulmonary Drug Delivery Systems Average Price by Application (2018-2029)

7 North America
    7.1 North America Pulmonary Drug Delivery Systems Sales Quantity by Type (2018-2029)
    7.2 North America Pulmonary Drug Delivery Systems Sales Quantity by Application (2018-2029)
    7.3 North America Pulmonary Drug Delivery Systems Market Size by Country
        7.3.1 North America Pulmonary Drug Delivery Systems Sales Quantity by Country (2018-2029)
        7.3.2 North America Pulmonary Drug Delivery Systems Consumption Value by Country (2018-2029)
        7.3.3 United States Market Size and Forecast (2018-2029)
        7.3.4 Canada Market Size and Forecast (2018-2029)
        7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe
    8.1 Europe Pulmonary Drug Delivery Systems Sales Quantity by Type (2018-2029)
    8.2 Europe Pulmonary Drug Delivery Systems Sales Quantity by Application (2018-2029)
    8.3 Europe Pulmonary Drug Delivery Systems Market Size by Country
        8.3.1 Europe Pulmonary Drug Delivery Systems Sales Quantity by Country (2018-2029)
        8.3.2 Europe Pulmonary Drug Delivery Systems Consumption Value by Country (2018-2029)
        8.3.3 Germany Market Size and Forecast (2018-2029)
        8.3.4 France Market Size and Forecast (2018-2029)
        8.3.5 United Kingdom Market Size and Forecast (2018-2029)
        8.3.6 Russia Market Size and Forecast (2018-2029)
        8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific
    9.1 Asia-Pacific Pulmonary Drug Delivery Systems Sales Quantity by Type (2018-2029)
    9.2 Asia-Pacific Pulmonary Drug Delivery Systems Sales Quantity by Application (2018-2029)
    9.3 Asia-Pacific Pulmonary Drug Delivery Systems Market Size by Region
        9.3.1 Asia-Pacific Pulmonary Drug Delivery Systems Sales Quantity by Region (2018-2029)
        9.3.2 Asia-Pacific Pulmonary Drug Delivery Systems Consumption Value by Region (2018-2029)
        9.3.3 China Market Size and Forecast (2018-2029)
        9.3.4 Japan Market Size and Forecast (2018-2029)
        9.3.5 Korea Market Size and Forecast (2018-2029)
        9.3.6 India Market Size and Forecast (2018-2029)
        9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
        9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America
    10.1 South America Pulmonary Drug Delivery Systems Sales Quantity by Type (2018-2029)
    10.2 South America Pulmonary Drug Delivery Systems Sales Quantity by Application (2018-2029)
    10.3 South America Pulmonary Drug Delivery Systems Market Size by Country
        10.3.1 South America Pulmonary Drug Delivery Systems Sales Quantity by Country (2018-2029)
        10.3.2 South America Pulmonary Drug Delivery Systems Consumption Value by Country (2018-2029)
        10.3.3 Brazil Market Size and Forecast (2018-2029)
        10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa
    11.1 Middle East & Africa Pulmonary Drug Delivery Systems Sales Quantity by Type (2018-2029)
    11.2 Middle East & Africa Pulmonary Drug Delivery Systems Sales Quantity by Application (2018-2029)
    11.3 Middle East & Africa Pulmonary Drug Delivery Systems Market Size by Country
        11.3.1 Middle East & Africa Pulmonary Drug Delivery Systems Sales Quantity by Country (2018-2029)
        11.3.2 Middle East & Africa Pulmonary Drug Delivery Systems Consumption Value by Country (2018-2029)
        11.3.3 Turkey Market Size and Forecast (2018-2029)
        11.3.4 Egypt Market Size and Forecast (2018-2029)
        11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
        11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics
    12.1 Pulmonary Drug Delivery Systems Market Drivers
    12.2 Pulmonary Drug Delivery Systems Market Restraints
    12.3 Pulmonary Drug Delivery Systems Trends Analysis
    12.4 Porters Five Forces Analysis
        12.4.1 Threat of New Entrants
        12.4.2 Bargaining Power of Suppliers
        12.4.3 Bargaining Power of Buyers
        12.4.4 Threat of Substitutes
        12.4.5 Competitive Rivalry
    12.5 Influence of COVID-19 and Russia-Ukraine War
        12.5.1 Influence of COVID-19
        12.5.2 Influence of Russia-Ukraine War

13 Raw Material and Industry Chain
    13.1 Raw Material of Pulmonary Drug Delivery Systems and Key Manufacturers
    13.2 Manufacturing Costs Percentage of Pulmonary Drug Delivery Systems
    13.3 Pulmonary Drug Delivery Systems Production Process
    13.4 Pulmonary Drug Delivery Systems Industrial Chain

14 Shipments by Distribution Channel
    14.1 Sales Channel
        14.1.1 Direct to End-User
        14.1.2 Distributors
    14.2 Pulmonary Drug Delivery Systems Typical Distributors
    14.3 Pulmonary Drug Delivery Systems Typical Customers

15 Research Findings and Conclusion

16 Appendix
    16.1 Methodology
    16.2 Research Process and Data Source
    16.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Pulmonary Drug Delivery Systems Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 2. Global Pulmonary Drug Delivery Systems Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 3. 3M Basic Information, Manufacturing Base and Competitors
    Table 4. 3M Major Business
    Table 5. 3M Pulmonary Drug Delivery Systems Product and Services
    Table 6. 3M Pulmonary Drug Delivery Systems Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 7. 3M Recent Developments/Updates
    Table 8. GSK Basic Information, Manufacturing Base and Competitors
    Table 9. GSK Major Business
    Table 10. GSK Pulmonary Drug Delivery Systems Product and Services
    Table 11. GSK Pulmonary Drug Delivery Systems Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 12. GSK Recent Developments/Updates
    Table 13. AstraZeneca Basic Information, Manufacturing Base and Competitors
    Table 14. AstraZeneca Major Business
    Table 15. AstraZeneca Pulmonary Drug Delivery Systems Product and Services
    Table 16. AstraZeneca Pulmonary Drug Delivery Systems Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 17. AstraZeneca Recent Developments/Updates
    Table 18. Cipla Basic Information, Manufacturing Base and Competitors
    Table 19. Cipla Major Business
    Table 20. Cipla Pulmonary Drug Delivery Systems Product and Services
    Table 21. Cipla Pulmonary Drug Delivery Systems Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 22. Cipla Recent Developments/Updates
    Table 23. Chiesi Basic Information, Manufacturing Base and Competitors
    Table 24. Chiesi Major Business
    Table 25. Chiesi Pulmonary Drug Delivery Systems Product and Services
    Table 26. Chiesi Pulmonary Drug Delivery Systems Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 27. Chiesi Recent Developments/Updates
    Table 28. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
    Table 29. Boehringer Ingelheim Major Business
    Table 30. Boehringer Ingelheim Pulmonary Drug Delivery Systems Product and Services
    Table 31. Boehringer Ingelheim Pulmonary Drug Delivery Systems Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 32. Boehringer Ingelheim Recent Developments/Updates
    Table 33. Aptar Basic Information, Manufacturing Base and Competitors
    Table 34. Aptar Major Business
    Table 35. Aptar Pulmonary Drug Delivery Systems Product and Services
    Table 36. Aptar Pulmonary Drug Delivery Systems Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 37. Aptar Recent Developments/Updates
    Table 38. Novartis Basic Information, Manufacturing Base and Competitors
    Table 39. Novartis Major Business
    Table 40. Novartis Pulmonary Drug Delivery Systems Product and Services
    Table 41. Novartis Pulmonary Drug Delivery Systems Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 42. Novartis Recent Developments/Updates
    Table 43. Philips Respironics Basic Information, Manufacturing Base and Competitors
    Table 44. Philips Respironics Major Business
    Table 45. Philips Respironics Pulmonary Drug Delivery Systems Product and Services
    Table 46. Philips Respironics Pulmonary Drug Delivery Systems Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 47. Philips Respironics Recent Developments/Updates
    Table 48. Omron Healthcare Basic Information, Manufacturing Base and Competitors
    Table 49. Omron Healthcare Major Business
    Table 50. Omron Healthcare Pulmonary Drug Delivery Systems Product and Services
    Table 51. Omron Healthcare Pulmonary Drug Delivery Systems Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 52. Omron Healthcare Recent Developments/Updates
    Table 53. PARI Basic Information, Manufacturing Base and Competitors
    Table 54. PARI Major Business
    Table 55. PARI Pulmonary Drug Delivery Systems Product and Services
    Table 56. PARI Pulmonary Drug Delivery Systems Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 57. PARI Recent Developments/Updates
    Table 58. Skyepharma Basic Information, Manufacturing Base and Competitors
    Table 59. Skyepharma Major Business
    Table 60. Skyepharma Pulmonary Drug Delivery Systems Product and Services
    Table 61. Skyepharma Pulmonary Drug Delivery Systems Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 62. Skyepharma Recent Developments/Updates
    Table 63. CareFusion Basic Information, Manufacturing Base and Competitors
    Table 64. CareFusion Major Business
    Table 65. CareFusion Pulmonary Drug Delivery Systems Product and Services
    Table 66. CareFusion Pulmonary Drug Delivery Systems Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 67. CareFusion Recent Developments/Updates
    Table 68. Shanghai Huarui Basic Information, Manufacturing Base and Competitors
    Table 69. Shanghai Huarui Major Business
    Table 70. Shanghai Huarui Pulmonary Drug Delivery Systems Product and Services
    Table 71. Shanghai Huarui Pulmonary Drug Delivery Systems Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 72. Shanghai Huarui Recent Developments/Updates
    Table 73. Taian Character Basic Information, Manufacturing Base and Competitors
    Table 74. Taian Character Major Business
    Table 75. Taian Character Pulmonary Drug Delivery Systems Product and Services
    Table 76. Taian Character Pulmonary Drug Delivery Systems Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 77. Taian Character Recent Developments/Updates
    Table 78. Chia Tai Tianqing Basic Information, Manufacturing Base and Competitors
    Table 79. Chia Tai Tianqing Major Business
    Table 80. Chia Tai Tianqing Pulmonary Drug Delivery Systems Product and Services
    Table 81. Chia Tai Tianqing Pulmonary Drug Delivery Systems Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 82. Chia Tai Tianqing Recent Developments/Updates
    Table 83. Global Pulmonary Drug Delivery Systems Sales Quantity by Manufacturer (2018-2023) & (K Units)
    Table 84. Global Pulmonary Drug Delivery Systems Revenue by Manufacturer (2018-2023) & (USD Million)
    Table 85. Global Pulmonary Drug Delivery Systems Average Price by Manufacturer (2018-2023) & (USD/Unit)
    Table 86. Market Position of Manufacturers in Pulmonary Drug Delivery Systems, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
    Table 87. Head Office and Pulmonary Drug Delivery Systems Production Site of Key Manufacturer
    Table 88. Pulmonary Drug Delivery Systems Market: Company Product Type Footprint
    Table 89. Pulmonary Drug Delivery Systems Market: Company Product Application Footprint
    Table 90. Pulmonary Drug Delivery Systems New Market Entrants and Barriers to Market Entry
    Table 91. Pulmonary Drug Delivery Systems Mergers, Acquisition, Agreements, and Collaborations
    Table 92. Global Pulmonary Drug Delivery Systems Sales Quantity by Region (2018-2023) & (K Units)
    Table 93. Global Pulmonary Drug Delivery Systems Sales Quantity by Region (2024-2029) & (K Units)
    Table 94. Global Pulmonary Drug Delivery Systems Consumption Value by Region (2018-2023) & (USD Million)
    Table 95. Global Pulmonary Drug Delivery Systems Consumption Value by Region (2024-2029) & (USD Million)
    Table 96. Global Pulmonary Drug Delivery Systems Average Price by Region (2018-2023) & (USD/Unit)
    Table 97. Global Pulmonary Drug Delivery Systems Average Price by Region (2024-2029) & (USD/Unit)
    Table 98. Global Pulmonary Drug Delivery Systems Sales Quantity by Type (2018-2023) & (K Units)
    Table 99. Global Pulmonary Drug Delivery Systems Sales Quantity by Type (2024-2029) & (K Units)
    Table 100. Global Pulmonary Drug Delivery Systems Consumption Value by Type (2018-2023) & (USD Million)
    Table 101. Global Pulmonary Drug Delivery Systems Consumption Value by Type (2024-2029) & (USD Million)
    Table 102. Global Pulmonary Drug Delivery Systems Average Price by Type (2018-2023) & (USD/Unit)
    Table 103. Global Pulmonary Drug Delivery Systems Average Price by Type (2024-2029) & (USD/Unit)
    Table 104. Global Pulmonary Drug Delivery Systems Sales Quantity by Application (2018-2023) & (K Units)
    Table 105. Global Pulmonary Drug Delivery Systems Sales Quantity by Application (2024-2029) & (K Units)
    Table 106. Global Pulmonary Drug Delivery Systems Consumption Value by Application (2018-2023) & (USD Million)
    Table 107. Global Pulmonary Drug Delivery Systems Consumption Value by Application (2024-2029) & (USD Million)
    Table 108. Global Pulmonary Drug Delivery Systems Average Price by Application (2018-2023) & (USD/Unit)
    Table 109. Global Pulmonary Drug Delivery Systems Average Price by Application (2024-2029) & (USD/Unit)
    Table 110. North America Pulmonary Drug Delivery Systems Sales Quantity by Type (2018-2023) & (K Units)
    Table 111. North America Pulmonary Drug Delivery Systems Sales Quantity by Type (2024-2029) & (K Units)
    Table 112. North America Pulmonary Drug Delivery Systems Sales Quantity by Application (2018-2023) & (K Units)
    Table 113. North America Pulmonary Drug Delivery Systems Sales Quantity by Application (2024-2029) & (K Units)
    Table 114. North America Pulmonary Drug Delivery Systems Sales Quantity by Country (2018-2023) & (K Units)
    Table 115. North America Pulmonary Drug Delivery Systems Sales Quantity by Country (2024-2029) & (K Units)
    Table 116. North America Pulmonary Drug Delivery Systems Consumption Value by Country (2018-2023) & (USD Million)
    Table 117. North America Pulmonary Drug Delivery Systems Consumption Value by Country (2024-2029) & (USD Million)
    Table 118. Europe Pulmonary Drug Delivery Systems Sales Quantity by Type (2018-2023) & (K Units)
    Table 119. Europe Pulmonary Drug Delivery Systems Sales Quantity by Type (2024-2029) & (K Units)
    Table 120. Europe Pulmonary Drug Delivery Systems Sales Quantity by Application (2018-2023) & (K Units)
    Table 121. Europe Pulmonary Drug Delivery Systems Sales Quantity by Application (2024-2029) & (K Units)
    Table 122. Europe Pulmonary Drug Delivery Systems Sales Quantity by Country (2018-2023) & (K Units)
    Table 123. Europe Pulmonary Drug Delivery Systems Sales Quantity by Country (2024-2029) & (K Units)
    Table 124. Europe Pulmonary Drug Delivery Systems Consumption Value by Country (2018-2023) & (USD Million)
    Table 125. Europe Pulmonary Drug Delivery Systems Consumption Value by Country (2024-2029) & (USD Million)
    Table 126. Asia-Pacific Pulmonary Drug Delivery Systems Sales Quantity by Type (2018-2023) & (K Units)
    Table 127. Asia-Pacific Pulmonary Drug Delivery Systems Sales Quantity by Type (2024-2029) & (K Units)
    Table 128. Asia-Pacific Pulmonary Drug Delivery Systems Sales Quantity by Application (2018-2023) & (K Units)
    Table 129. Asia-Pacific Pulmonary Drug Delivery Systems Sales Quantity by Application (2024-2029) & (K Units)
    Table 130. Asia-Pacific Pulmonary Drug Delivery Systems Sales Quantity by Region (2018-2023) & (K Units)
    Table 131. Asia-Pacific Pulmonary Drug Delivery Systems Sales Quantity by Region (2024-2029) & (K Units)
    Table 132. Asia-Pacific Pulmonary Drug Delivery Systems Consumption Value by Region (2018-2023) & (USD Million)
    Table 133. Asia-Pacific Pulmonary Drug Delivery Systems Consumption Value by Region (2024-2029) & (USD Million)
    Table 134. South America Pulmonary Drug Delivery Systems Sales Quantity by Type (2018-2023) & (K Units)
    Table 135. South America Pulmonary Drug Delivery Systems Sales Quantity by Type (2024-2029) & (K Units)
    Table 136. South America Pulmonary Drug Delivery Systems Sales Quantity by Application (2018-2023) & (K Units)
    Table 137. South America Pulmonary Drug Delivery Systems Sales Quantity by Application (2024-2029) & (K Units)
    Table 138. South America Pulmonary Drug Delivery Systems Sales Quantity by Country (2018-2023) & (K Units)
    Table 139. South America Pulmonary Drug Delivery Systems Sales Quantity by Country (2024-2029) & (K Units)
    Table 140. South America Pulmonary Drug Delivery Systems Consumption Value by Country (2018-2023) & (USD Million)
    Table 141. South America Pulmonary Drug Delivery Systems Consumption Value by Country (2024-2029) & (USD Million)
    Table 142. Middle East & Africa Pulmonary Drug Delivery Systems Sales Quantity by Type (2018-2023) & (K Units)
    Table 143. Middle East & Africa Pulmonary Drug Delivery Systems Sales Quantity by Type (2024-2029) & (K Units)
    Table 144. Middle East & Africa Pulmonary Drug Delivery Systems Sales Quantity by Application (2018-2023) & (K Units)
    Table 145. Middle East & Africa Pulmonary Drug Delivery Systems Sales Quantity by Application (2024-2029) & (K Units)
    Table 146. Middle East & Africa Pulmonary Drug Delivery Systems Sales Quantity by Region (2018-2023) & (K Units)
    Table 147. Middle East & Africa Pulmonary Drug Delivery Systems Sales Quantity by Region (2024-2029) & (K Units)
    Table 148. Middle East & Africa Pulmonary Drug Delivery Systems Consumption Value by Region (2018-2023) & (USD Million)
    Table 149. Middle East & Africa Pulmonary Drug Delivery Systems Consumption Value by Region (2024-2029) & (USD Million)
    Table 150. Pulmonary Drug Delivery Systems Raw Material
    Table 151. Key Manufacturers of Pulmonary Drug Delivery Systems Raw Materials
    Table 152. Pulmonary Drug Delivery Systems Typical Distributors
    Table 153. Pulmonary Drug Delivery Systems Typical Customers
List of Figures
    Figure 1. Pulmonary Drug Delivery Systems Picture
    Figure 2. Global Pulmonary Drug Delivery Systems Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 3. Global Pulmonary Drug Delivery Systems Consumption Value Market Share by Type in 2022
    Figure 4. Nebulizers Examples
    Figure 5. Dry Powder Inhaler (DPI) Examples
    Figure 6. Metered Dose Inhaler (MDI) Examples
    Figure 7. Global Pulmonary Drug Delivery Systems Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Figure 8. Global Pulmonary Drug Delivery Systems Consumption Value Market Share by Application in 2022
    Figure 9. COPD Examples
    Figure 10. Asthma Examples
    Figure 11. Others Examples
    Figure 12. Global Pulmonary Drug Delivery Systems Consumption Value, (USD Million): 2018 & 2022 & 2029
    Figure 13. Global Pulmonary Drug Delivery Systems Consumption Value and Forecast (2018-2029) & (USD Million)
    Figure 14. Global Pulmonary Drug Delivery Systems Sales Quantity (2018-2029) & (K Units)
    Figure 15. Global Pulmonary Drug Delivery Systems Average Price (2018-2029) & (USD/Unit)
    Figure 16. Global Pulmonary Drug Delivery Systems Sales Quantity Market Share by Manufacturer in 2022
    Figure 17. Global Pulmonary Drug Delivery Systems Consumption Value Market Share by Manufacturer in 2022
    Figure 18. Producer Shipments of Pulmonary Drug Delivery Systems by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
    Figure 19. Top 3 Pulmonary Drug Delivery Systems Manufacturer (Consumption Value) Market Share in 2022
    Figure 20. Top 6 Pulmonary Drug Delivery Systems Manufacturer (Consumption Value) Market Share in 2022
    Figure 21. Global Pulmonary Drug Delivery Systems Sales Quantity Market Share by Region (2018-2029)
    Figure 22. Global Pulmonary Drug Delivery Systems Consumption Value Market Share by Region (2018-2029)
    Figure 23. North America Pulmonary Drug Delivery Systems Consumption Value (2018-2029) & (USD Million)
    Figure 24. Europe Pulmonary Drug Delivery Systems Consumption Value (2018-2029) & (USD Million)
    Figure 25. Asia-Pacific Pulmonary Drug Delivery Systems Consumption Value (2018-2029) & (USD Million)
    Figure 26. South America Pulmonary Drug Delivery Systems Consumption Value (2018-2029) & (USD Million)
    Figure 27. Middle East & Africa Pulmonary Drug Delivery Systems Consumption Value (2018-2029) & (USD Million)
    Figure 28. Global Pulmonary Drug Delivery Systems Sales Quantity Market Share by Type (2018-2029)
    Figure 29. Global Pulmonary Drug Delivery Systems Consumption Value Market Share by Type (2018-2029)
    Figure 30. Global Pulmonary Drug Delivery Systems Average Price by Type (2018-2029) & (USD/Unit)
    Figure 31. Global Pulmonary Drug Delivery Systems Sales Quantity Market Share by Application (2018-2029)
    Figure 32. Global Pulmonary Drug Delivery Systems Consumption Value Market Share by Application (2018-2029)
    Figure 33. Global Pulmonary Drug Delivery Systems Average Price by Application (2018-2029) & (USD/Unit)
    Figure 34. North America Pulmonary Drug Delivery Systems Sales Quantity Market Share by Type (2018-2029)
    Figure 35. North America Pulmonary Drug Delivery Systems Sales Quantity Market Share by Application (2018-2029)
    Figure 36. North America Pulmonary Drug Delivery Systems Sales Quantity Market Share by Country (2018-2029)
    Figure 37. North America Pulmonary Drug Delivery Systems Consumption Value Market Share by Country (2018-2029)
    Figure 38. United States Pulmonary Drug Delivery Systems Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 39. Canada Pulmonary Drug Delivery Systems Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 40. Mexico Pulmonary Drug Delivery Systems Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 41. Europe Pulmonary Drug Delivery Systems Sales Quantity Market Share by Type (2018-2029)
    Figure 42. Europe Pulmonary Drug Delivery Systems Sales Quantity Market Share by Application (2018-2029)
    Figure 43. Europe Pulmonary Drug Delivery Systems Sales Quantity Market Share by Country (2018-2029)
    Figure 44. Europe Pulmonary Drug Delivery Systems Consumption Value Market Share by Country (2018-2029)
    Figure 45. Germany Pulmonary Drug Delivery Systems Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 46. France Pulmonary Drug Delivery Systems Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 47. United Kingdom Pulmonary Drug Delivery Systems Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 48. Russia Pulmonary Drug Delivery Systems Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 49. Italy Pulmonary Drug Delivery Systems Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 50. Asia-Pacific Pulmonary Drug Delivery Systems Sales Quantity Market Share by Type (2018-2029)
    Figure 51. Asia-Pacific Pulmonary Drug Delivery Systems Sales Quantity Market Share by Application (2018-2029)
    Figure 52. Asia-Pacific Pulmonary Drug Delivery Systems Sales Quantity Market Share by Region (2018-2029)
    Figure 53. Asia-Pacific Pulmonary Drug Delivery Systems Consumption Value Market Share by Region (2018-2029)
    Figure 54. China Pulmonary Drug Delivery Systems Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 55. Japan Pulmonary Drug Delivery Systems Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 56. Korea Pulmonary Drug Delivery Systems Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 57. India Pulmonary Drug Delivery Systems Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 58. Southeast Asia Pulmonary Drug Delivery Systems Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 59. Australia Pulmonary Drug Delivery Systems Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 60. South America Pulmonary Drug Delivery Systems Sales Quantity Market Share by Type (2018-2029)
    Figure 61. South America Pulmonary Drug Delivery Systems Sales Quantity Market Share by Application (2018-2029)
    Figure 62. South America Pulmonary Drug Delivery Systems Sales Quantity Market Share by Country (2018-2029)
    Figure 63. South America Pulmonary Drug Delivery Systems Consumption Value Market Share by Country (2018-2029)
    Figure 64. Brazil Pulmonary Drug Delivery Systems Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 65. Argentina Pulmonary Drug Delivery Systems Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 66. Middle East & Africa Pulmonary Drug Delivery Systems Sales Quantity Market Share by Type (2018-2029)
    Figure 67. Middle East & Africa Pulmonary Drug Delivery Systems Sales Quantity Market Share by Application (2018-2029)
    Figure 68. Middle East & Africa Pulmonary Drug Delivery Systems Sales Quantity Market Share by Region (2018-2029)
    Figure 69. Middle East & Africa Pulmonary Drug Delivery Systems Consumption Value Market Share by Region (2018-2029)
    Figure 70. Turkey Pulmonary Drug Delivery Systems Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 71. Egypt Pulmonary Drug Delivery Systems Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 72. Saudi Arabia Pulmonary Drug Delivery Systems Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 73. South Africa Pulmonary Drug Delivery Systems Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 74. Pulmonary Drug Delivery Systems Market Drivers
    Figure 75. Pulmonary Drug Delivery Systems Market Restraints
    Figure 76. Pulmonary Drug Delivery Systems Market Trends
    Figure 77. Porters Five Forces Analysis
    Figure 78. Manufacturing Cost Structure Analysis of Pulmonary Drug Delivery Systems in 2022
    Figure 79. Manufacturing Process Analysis of Pulmonary Drug Delivery Systems
    Figure 80. Pulmonary Drug Delivery Systems Industrial Chain
    Figure 81. Sales Quantity Channel: Direct to End-User vs Distributors
    Figure 82. Direct Channel Pros & Cons
    Figure 83. Indirect Channel Pros & Cons
    Figure 84. Methodology
    Figure 85. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Related Reports

Global Pulmonary Drug Delivery Systems Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Pulmonary Drug Delivery Systems Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 02 Jan 2024

date Medical Devices & Consumables

According to our (Global Info Research) latest study, the global Pulmonary Drug Delivery Systems market size was valued at USD 3134.3 million in 2023 and is forecast to a readjusted size of USD 4129.9 million by 2030 with a CAGR of 4.0% during review period.

Global Pulmonary Drug Delivery Systems Supply, Demand and Key Producers, 2024-2030

Global Pulmonary Drug Delivery Systems Supply, Demand and Key Producers, 2024-2030

date 18 Feb 2024

date Medical Devices & Consumables

The global Pulmonary Drug Delivery Systems market size is expected to reach $ 4129.9 million by 2030, rising at a market growth of 4.0% CAGR during the forecast period (2024-2030).

Product Tags

Pulmonary Drug Delivery Systems

Blood Plasma Refrigerator

ENT Camera System

Medical Repair Titanium Mesh

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>